Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotransplant(BTRN) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (80)	9/15/1998 9:50:00 AM
From: scaram(o)uche	Read Replies (1) \| Respond to of 1475

[ sort of on-topic ] Tuesday September 15, 7:30 am Eastern Time Company Press Release SOURCE: Human Genome Sciences, Inc. Human Genome Sciences Announces Resignation of Melvin D. Booth ROCKVILLE, Md., Sept. 15 /PRNewswire/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI - news) announced today that Melvin D. Booth has resigned as President and Chief Operating Officer, and as a member of the Board of Directors, effective November 13, 1998. Mr. Booth has served in these positions since July 1995. Mr. Booth is leaving HGSI to become President and Chief Operating Officer of MedImmune, Inc. (Nasdaq: MEDI - news). (snip)